Scaling new heights in the fight against heart disease
Founded by leading cardiovascular scientists, our team has the tenacity to pursue our ultimate peak – changing the treatment paradigm for heart disease, and in doing so improving and extending the lives of millions of individuals and families fighting this debilitating disease.
We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.
We are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.
LATEST NEWS
Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 12, 2021-- Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that it will present new
Read MoreTenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 30, 2021-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that Faraz Ali , Chief Executive
Read MoreTenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
- TN-201 MYBPC3 gene therapy product candidate for the leading genetic cause of hypertrophic cardiomyopathy granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) - Expanded leadership team appointing Leone Patterson as Chief Financial and Business Officer and Matt
Read MoreJOIN OUR TEAM
Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.
